𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Frequent detection of cell-associated HIV-1 RNA in patients with plasma viral load <50 copies/ml

✍ Scribed by Bernd Kupfer; Bertfried Matz; Martin P. Däumer; Fabienne Roden; Jürgen K. Rockstroh; Nazifa Qurishi; Ulrich Spengler; Rolf Kaiser


Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
129 KB
Volume
79
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Despite prolonged undetectable plasma viral load some HIV‐1 infected patients have been reported to develop resistance‐associated mutations leading to treatment failure. The mechanisms for this phenomenon and the point of origin for residual viral evolution are still not elucidated. In order to quantify cell‐associated HIV‐1 RNA in patients with different levels of plasma viremia paired cell‐associated HIV‐1 RNA loads and plasma viral loads were determined. Weak inverse correlation between these parameters and the amounts of CD4^+^ T cells was observed, whereas there was no correlation between viral loads and CD8^+^ T cells or CD14^+^ monocytes, respectively. In a subset of patients, cell‐associated and plasma HIV‐1 env V3 sequences were analyzed. Plasma viral load and the amount of cell‐associated HIV‐RNA correlated strongly. However, in 62.3% of patients with undetectable plasma viral load cell‐associated HIV‐RNA could be detected. Analyses of HIV‐RNA in plasma and blood cells showed identical sequences in 4/19 patients, whereas the majority of patients had differing HIV‐1 RNA sequences in plasma and cells, respectively. In summary, this study shows that residual viral replication in peripheral blood still occurs in the majority of patients with undetectable plasma viral load. Since these replication events could lead to ongoing viral evolution it should be considered to optimize antiretroviral therapy in order to minimize the development of drug resistance. J. Med. Virol. 79:1440–1445, 2007. © Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Detection of drug resistance mutations a
✍ Chris Verhofstede; Filip Van Wanzeele; Bea Van Der Gucht; Jolanda Pelgrom; Linos 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB

## Abstract In order to evaluate the usefulness of resistance testing after a viral rebound with plasma HIV RNA levels of less than 1,000 copies (c)/ml, genotyping was performed on 39 samples from patients on highly active antiretroviral therapy (HAART) showing a viremia of over 50 c/ml up to a max

Changes in HIV RNA viral load, CD4+ T-ce
✍ Mireille Kalou; Madeleine Sassan-Morokro; Lucien Abouya; Célestin Bile; Chantal 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

## Abstract We analyzed changes in plasma human immunodeficiency virus (HIV)‐1 viral load, CD4+ T‐cell count, and markers of immune activation markers at start of treatment of tuberculosis and 12 months after among 44 HIV‐1‐infected patients with newly diagnosed, sputum‐smear positive for __Mycobac